Literature DB >> 7723657

Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine.

J V Newman1, R Kolter, D C Laux, P S Cohen.   

Abstract

Escherichia coli F-18, a normal human fecal isolate, is an excellent colonizer of the streptomycin-treated mouse large intestine. E. coli F-18 Col-, a derivative of E. coli F-18 that no longer makes the E. coli F-18 colicin, colonizes the mouse large intestine as well as E. coli F-18 when fed alone, but is eliminated when fed together with E. coli F-18. Recently, a random bank of E. coli F-18 DNA was transformed into E. coli F-18 Col-, the resultant population was fed to streptomycin-treated mice, and the intestine was used to select the best colonizer. In this fashion, a 6.5 kb E. coli F-18 DNA fragment was isolated. This fragment was shown to enhance E. coli F-18 Col- mouse large intestinal colonizing ability and survival during stationary phase in intestinal mucus in vitro, as well as stimulate the synthesis of type-1 fimbriae. Here, we present evidence that the gene responsible for the enhanced E. coli F-18 Col- colonizing ability and survival during stationary phase in vitro is leuX. This gene encodes a rare leucine tRNA specific for the UUG codon. In addition, we show that the presence of a functional leuX gene is necessary for E. coli K-12 intestinal colonization and for survival in stationary phase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7723657     DOI: 10.1006/mpat.1994.1076

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  15 in total

1.  Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources.

Authors:  Mary P Leatham; Sarah J Stevenson; Eric J Gauger; Karen A Krogfelt; Jeremy J Lins; Traci L Haddock; Steven M Autieri; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Influence of cloned tRNA genes from a uropathogenic Escherichia coli strain on adherence to primary human renal tubular epithelial cells and nephropathogenicity in rats.

Authors:  M Susa; B Kreft; G Wasenauer; A Ritter; J Hacker; R Marre
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Commensal and Pathogenic Escherichia coli Metabolism in the Gut.

Authors:  Tyrrell Conway; Paul S Cohen
Journal:  Microbiol Spectr       Date:  2015-06

4.  The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota.

Authors:  Mary P Leatham-Jensen; Jakob Frimodt-Møller; Jimmy Adediran; Matthew E Mokszycki; Megan E Banner; Joyce E Caughron; Karen A Krogfelt; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

5.  Role of motility and the flhDC Operon in Escherichia coli MG1655 colonization of the mouse intestine.

Authors:  Eric J Gauger; Mary P Leatham; Regino Mercado-Lubo; David C Laux; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

6.  Growth of Vibrio anguillarum in Salmon Intestinal Mucus.

Authors:  T Garcia; K Otto; S Kjelleberg; D R Nelson
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

7.  Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.

Authors:  Regina L Miranda; Tyrrell Conway; Mary P Leatham; Dong Eun Chang; Wendy E Norris; James H Allen; Sarah J Stevenson; David C Laux; Paul S Cohen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium.

Authors:  Steven M Autieri; Jeremy J Lins; Mary P Leatham; David C Laux; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

9.  The capability of catabolic utilization of N-acetylneuraminic acid, a sialic acid, is essential for Vibrio vulnificus pathogenesis.

Authors:  Hee Gon Jeong; Man Hwan Oh; Byoung Sik Kim; Min Young Lee; Ho Jae Han; Sang Ho Choi
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

10.  Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.

Authors:  Osnat Gillor; Itamar Giladi; Margaret A Riley
Journal:  BMC Microbiol       Date:  2009-08-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.